Results 51 to 60 of about 4,004 (136)
Standardized Reporting of Cardiac Magnetic Resonance Examinations in Children With Cardiac Diseases and Adults With Congenital Heart Disease: A Scientific Statement From the Association for European Pediatric and Congenital Cardiology (AEPC) and the International Society for Magnetic Resonance in Medicine (ISMRM)
Journal of Magnetic Resonance Imaging, EarlyView.Francesca Raimondi, Inga Voges, Lamia Ait‐Ali, Sonya Babu‐Narayan, Rene Botnar, Barbara Burkhardt, Adrienne Campbell‐Washburn, Dominik Daniel Gabbert, Georg Hansmann, Willem A. Helbing, Hasan Hosan, Sylvia Krupickova, Heiner Latus, Duarte Martins, Colin McMahon, Christian Meierhofer, Vivek Muthurangu, Tiina Ojala, Pim van Ooij, Claudia Prieto, Milan Prsa, Kuberan Pushparajah, José F. Rodríguez Palomares, Samir Sarikouch, Lars Grosse‐Wortman, F. Gerald Greil, Heynric Grotenhuis +26 morewiley +1 more sourceOutcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2345-2352, June 1, 2026.ABSTRACT Background
Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim
The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.Aamer Ubaid, Arindam Bagga, Kevin Kennedy, John T. Saxon, Chetan P. Huded +4 morewiley +1 more sourceImpact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Atrial fibrillation (AF) and mitral regurgitation (MR) are closely linked, and one may worsen the other. We investigated the impact of baseline AF in patients with MR undergoing transcatheter edge‐to‐edge repair.Carlo Mannina, Akarsh Sharma, Yash Prakash, Andreina Carbone, Eduardo Bossone, Antonino Tuttolomondo, Edgar Argulian, Sahil Khera, Parasuram Melarcode‐Krishnamoorthy, George Dangas, Jonathan Halperin, Gilbert H. L. Tang, Samin Sharma, Annapoorna Kini, Gregg W. Stone, Stamatios Lerakis +15 moredoaj +1 more sourceTranscatheter Treatment Options for Functional Mitral Regurgitation: Which Device for Which Patients?
Interventional Cardiology: Reviews, Research, ResourcesMitral regurgitation is the most common valvular disease in the developed world, with approximately 24.2 million people being affected worldwide and a higher prevalence in older age groups.Stephanie K Tom, Kanika Kalra, Emily Perdoncin, Andy Tully, Chandan M Devireddy, Errol Inci, Adam Greenbaum, Kendra J Grubb +7 moredoaj +1 more sourceCardiovascular Health in Women—Across the Lifespan
Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.ABSTRACT
Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee +5 morewiley +1 more sourceFrom Clinic to Computation: Multiscale Bioengineering Strategies for Durable Biological Aortic Valve Replacements
Advanced Functional Materials, Volume 36, Issue 39, 14 May 2026.Bioprosthetic aortic valves have revolutionized the treatment of aortic stenosis, but their durability is limited by structural valve deterioration (SVD). This review focuses on the pericardial tissue at the heart of these valves, examining how its mechanical properties and calcification drive fatigue and failure.Gabriele Greco, Pierfrancesco Gaziano, Serena Anglese, Simone Morganti, Carlo de Vincentiis, Ferdinando Auricchio, Michele Marino, Michele Conti +7 morewiley +1 more sourceComputational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling
Advanced Healthcare Materials, Volume 15, Issue 17, 8 May 2026.Emerging advances in three‐dimensional bioprinting and computational modeling are reshaping cardiovascular (CV) research by enabling more realistic, patient‐specific tissue platforms. This review surveys cutting‐edge approaches that merge biomimetic CV constructs with computational simulations to overcome the limitations of traditional models, improve ...Tanmay Mukherjee, Mehdi Salar Amoli, Sarah Rezapourdamanab, Lama Rita El Shammas, Martin L. Tomov, Emilio A. Mendiola, Vahid Serpooshan, Reza Avazmohammadi +7 morewiley +1 more sourcePrognostic Value of Right Ventricular Afterload in Patients Undergoing Mitral Transcatheter Edge‐to‐Edge Repair
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Pulmonary hypertension (PH) and secondary mitral regurgitation (MR) are associated with adverse outcomes after mitral transcatheter edge‐to‐edge repair. We aim to study the prognostic value of invasively measured right ventricular afterload in Rody G. Bou Chaaya, Taha Hatab, Sahar Samimi, Fatima Qamar, Chloe Kharsa, Joe Aoun, Nadeen Faza, Stephen H. Little, Marvin D. Atkins, Michael J. Reardon, Neal S. Kleiman, Sherif F. Nagueh, William A. Zoghbi, Ashrith Guha, Syed Zaid, Sachin S. Goel +15 moredoaj +1 more sourceUtilization and Outcomes of Structural Heart Disease Interventions in Patients With Prior Mediastinal Radiation
JACC: AdvancesBackground: Outcomes of structural heart disease (SHD) interventions may be affected by prior mediastinal radiation. Objectives: The objective of the study was to evaluate the outcomes of SHD interventions among patients with vs without prior mediastinal Mahmoud Ismayl, MBBS, Hasaan Ahmed, MD, Andrew M. Goldsweig, MD, MS, Joerg Herrmann, MD, Mackram F. Eleid, MD, Charanjit S. Rihal, MD, Mayra Guerrero, MD +6 moredoaj +1 more sourcePreprocedural New York Heart Association Class IV Independently Predicts Mortality After Effective Edge-To-Edge Repair for Primary Mitral Regurgitation
Structural HeartBackground: In patients with primary mitral regurgitation (MR) (PMR), advanced symptoms classified as New York Heart Association (NYHA) class IV are typically driven by valve deterioration.Benedikt Koell, M.D., Lydia X. Plewe, M.D., Sebastian Ludwig, M.D., Jessica Weimann, M.Sc., Dhairya Patel, M.D., Lukas Stolz, M.D., Tetsu Tanaka, M.D., Teresa Trenkwalder, M.D., Felix Rudolph, M.D., Daryoush Samim, M.D., Philipp von Stein, M.D., Cristina Giannini, M.D., Julien Dreyfus, M.D., Andrea Scotti, M.D., Jean-Michel Paradis, M.D., Marianna Adamo, M.D., Nicole Karam, M.D., Yohann Bohbot, M.D., Anne Bernard, M.D., Bruno Melica, M.D., Yusuke Kobari, M.D., Yoan Lavie-Badie, M.D., Mirjam Kessler, M.D., Omar Chehab, M.D., Simon Redwood, M.D., Edith Lubos, M.D., Ole de Baker, M.D., Marco Metra, M.D., Azeem Latib, M.D., Chiara Primerano, M.D., Christos Iliadis, M.D., Fabien Praz, M.D., Muhammed Gerçek, M.D., Erion Xhepa, M.D., Marcel Weber, M.D., Raj Makkar, M.D., Juan Granada, M.D., Thomas Modine, M.D., Erwan Donal, M.D., Jörg Hausleiter, M.D., Augustin Coisne, M.D., Daniel Kalbacher, M.D., Anna Sonia Petronio, Marcel Weber, M.D., Tobias Rheude, M.D., Volker Rudolph, M.D., Stephan Windecker, M.D., Stéphane Lafitte, M.D., Guillaume Bonnet, M.D., Roman Pfister, M.D., Arnaud Sudre, M.D., Natacha Rousse, M.D., Corentin Bourg, M.D., Guillaume L'official, M.D., Mohammed Nejjari, M.D., David Attias, M.D., Edoardo Pancaldi, M.D., Paul Achouh, M.D., Alain Berrebi, M.D., Christophe Tribouilloy, M.D., Dan Rusinaru, M.D., Christophe Saint-Etienne, M.D., Marine Mevelec, M.D., Thibault Lhermusier, M.D., Frederic Bouisset, M.D., Dimitry Schewel, M.D., Jury Schewel, M.D. +66 moredoaj +1 more source